Literature DB >> 12576487

Dimerization and signal transduction of the growth hormone receptor.

Jürgen Gent1, Monique Van Den Eijnden, Peter Van Kerkhof, Ger J Strous.   

Abstract

GH binding to cell surface-localized GH receptors (GHRs) induces a conformational change of the dimerized receptors, resulting in activation of Janus kinase 2 and downstream signaling pathways. Interactions between the extracellular subdomain 2 of adjacent GHR polypeptides result in a 500-A2 contact interface, which has previously been suggested to stabilize the GH-(GHR)2 complex. In this study, we investigated further the role of subdomain 2 in GHR function. Amino acids that participate in (e.g. aspartic acid 152, tyrosine 200, or serine 201) or lie close to (e.g. asparagine 143 or cysteine 241) the contact interface were mutated in rabbit GHR. Surprisingly, none of the mutations affected GHR dimerization, as demonstrated by coimmunoprecipitation of a truncated, epitope-tagged GHR. However, signal transduction of GHR(D152H), GHR(Y200D), and GHR(S201K) mutants was precluded. More insight into the molecular mechanism of the signaling defect was obtained when we examined the effect of the mutations on the integrity of the GH-(GHR)2 complex in a protease-protection assay. In contrast to wild-type GHR, GHR(N143K), and GHR(C241S), the GHR(D152H), GHR(Y200D), and GHR(S201K) mutants were not protected against protease digestion by GH, indicating that a structural change is prevented. Together, we provide new evidence for a critical role of aspartic acid 152, tyrosine 200, and serine 201 of the GHR contact interface in the GH-induced conformational change to a signaling-competent complex rather than in GHR dimerization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576487     DOI: 10.1210/me.2002-0261

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

Review 1.  Suppressors of cytokine signaling in health and disease.

Authors:  Jane C Tan; Ralph Rabkin
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

2.  Lateral ligand-receptor interactions on membranes probed by simultaneous fluorescence-interference detection.

Authors:  Martynas Gavutis; Suman Lata; Peter Lamken; Pia Müller; Jacob Piehler
Journal:  Biophys J       Date:  2005-03-18       Impact factor: 4.033

3.  Growth hormone and in vitro maturation of rhesus macaque oocytes and subsequent embryo development.

Authors:  Jenna K Nyholt de Prada; Catherine A VandeVoort
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

4.  Effects of muscular strength training and growth hormone (GH) supplementation on femoral bone tissue: analysis by Raman spectroscopy, dual-energy X-ray absorptiometry, and mechanical resistance.

Authors:  Robson Chacon Castoldi; Guilherme Akio Tamura Ozaki; Thiago Alves Garcia; Ines Cristina Giometti; Tatiana Emy Koike; Regina Celi Trindade Camargo; João Domingos Augusto Dos Santos Pereira; Carlos José Leopoldo Constantino; Mário Jefferson Quirino Louzada; José Carlos Silva Camargo Filho; William Dias Belangero
Journal:  Lasers Med Sci       Date:  2019-06-15       Impact factor: 3.161

5.  Expression of the hepatic specific V1 messenger ribonucleic acid of the human growth hormone receptor gene is regulated by hepatic nuclear factor (HNF)-4alpha2 and HNF-4alpha8.

Authors:  Cynthia Gates Goodyer; Zakaria Rhani; Hong Zheng
Journal:  Mol Endocrinol       Date:  2007-11-08

Review 6.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

7.  Relationship between initial treatment effect of recombinant human growth hormone and exon 3 polymorphism of growth hormone receptor in Chinese children with growth hormone deficiency.

Authors:  Zhangqian Zheng; Lingfeng Cao; Zhou Pei; Dijing Zhi; Zhuhui Zhao; Li Xi; Ruoqian Cheng; Feihong Luo
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 8.  Rational design of competitive prolactin/growth hormone receptor antagonists.

Authors:  Estelle Tallet; Vincent Rouet; Jean-Baptiste Jomain; Paul A Kelly; Sophie Bernichtein; Vincent Goffin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

9.  NMR mapping of the IFNAR1-EC binding site on IFNalpha2 reveals allosteric changes in the IFNAR2-EC binding site.

Authors:  Sabine Ruth Akabayov; Zohar Biron; Peter Lamken; Jacob Piehler; Jacob Anglister
Journal:  Biochemistry       Date:  2010-02-02       Impact factor: 3.162

Review 10.  Nanomedicines in the treatment of acromegaly: focus on pegvisomant.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes Romijn
Journal:  Int J Nanomedicine       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.